Variant report
Variant | nsv892354 |
---|---|
Chromosome Location | chr9:11609469-11700487 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:11653547..11655405-chr9:11656471..11658764,2 | K562 | blood: | |
2 | chr9:11687941..11690802-chr9:11691495..11694345,3 | K562 | blood: | |
3 | chr9:11653547..11655405-chr9:11656471..11658764,2 | K562 | blood: | |
4 | chr9:11687941..11690802-chr9:11691495..11694345,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535374674 | chr9:11611602-11611603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs137968105 | chr9:11611622-11611623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574459002 | chr9:11611649-11611650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11787535 | chr9:11611655-11611656 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs572172963 | chr9:11611662-11611663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78695579 | chr9:11611666-11611667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560584888 | chr9:11611715-11611716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554015661 | chr9:11611732-11611733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539063502 | chr9:11612601-11612602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570696120 | chr9:11612603-11612604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76705127 | chr9:11612613-11612614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188641876 | chr9:11612615-11612616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561924094 | chr9:11612655-11612656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181283975 | chr9:11612673-11612674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541480701 | chr9:11612679-11612680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150555831 | chr9:11612709-11612710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139323145 | chr9:11612723-11612724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549917620 | chr9:11612738-11612739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150006704 | chr9:11612763-11612764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531635745 | chr9:11612774-11612775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34640360 | chr9:11618414-11618415 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs368560057 | chr9:11618427-11618428 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183535198 | chr9:11618437-11618438 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17239288 | chr9:11618444-11618445 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs547149823 | chr9:11618458-11618459 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563856320 | chr9:11618461-11618462 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532898094 | chr9:11618466-11618467 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549345071 | chr9:11618468-11618469 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569359492 | chr9:11618508-11618509 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
30 | rs187098706 | chr9:11618537-11618538 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190438983 | chr9:11618573-11618574 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535074769 | chr9:11618576-11618577 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566093952 | chr9:11618581-11618582 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535241691 | chr9:11618590-11618591 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558248002 | chr9:11618650-11618651 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs578130982 | chr9:11618652-11618653 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs77502643 | chr9:11618665-11618666 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368143306 | chr9:11618685-11618686 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557386035 | chr9:11618698-11618699 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10960027 | chr9:11618700-11618701 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574017357 | chr9:11618724-11618725 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551362881 | chr9:11618746-11618747 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562040199 | chr9:11618749-11618750 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114811142 | chr9:11618753-11618754 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540813803 | chr9:11618758-11618759 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563969523 | chr9:11618761-11618762 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149288309 | chr9:11618779-11618780 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145066079 | chr9:11618784-11618785 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564836670 | chr9:11625826-11625827 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2244547 | chr9:11625854-11625855 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Schizophrenia | 18511947 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11611600-11611800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:11612600-11612800 | Enhancers | Fetal Heart | heart |
3 | chr9:11618400-11618800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr9:11618600-11618800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr9:11625800-11627800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr9:11631200-11632200 | Enhancers | Fetal Brain Male | brain |
7 | chr9:11631400-11632000 | Enhancers | Fetal Brain Female | brain |
8 | chr9:11632000-11633000 | Weak transcription | Fetal Brain Female | brain |
9 | chr9:11632200-11633200 | Weak transcription | Fetal Brain Male | brain |
10 | chr9:11633000-11633200 | Enhancers | Fetal Brain Female | brain |
11 | chr9:11633200-11633600 | Enhancers | Fetal Brain Male | brain |
12 | chr9:11650200-11650600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr9:11656000-11656800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr9:11686800-11687400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr9:11696400-11696600 | Enhancers | Fetal Brain Male | brain |
16 | chr9:11696600-11697800 | Weak transcription | Fetal Brain Male | brain |
17 | chr9:11697800-11698400 | Enhancers | Fetal Brain Male | brain |
18 | chr9:11698400-11701800 | Weak transcription | Fetal Brain Male | brain |
19 | chr9:11698800-11701400 | Enhancers | Fetal Brain Female | brain |